Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 496 AL 510

Use of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease: A Systematic Review

Cardinali CAEF, Martins YA, Torrão AS.

Drugs Aging. 2021 Sep;38(9):769-791. doi: 10.1007/s40266-021-00878-y. Epub 2021 Aug 3.

Metabolism navigates neural cell fate in development, aging and neurodegeneration

Traxler L, Lagerwall J, Eichhorner S, Stefanoni D, D'Alessandro A, Mertens J.

Dis Model Mech. 2021 Aug 1;14(8):dmm048993. doi: 10.1242/dmm.048993. Epub 2021 Aug 4.

Melatonin and Sleep Disturbances in Alzheimer's Disease

Prodhan AHMSU, Cavestro C, Kamal MA, Islam MA.

CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.

Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols

Zhang M, Hu G, Shao N, Qin Y, Chen Q, Wang Y, Zhou P, Cai B.

Inflammopharmacology. 2021 Oct;29(5):1317-1329. doi: 10.1007/s10787-021-00861-4. Epub 2021 Aug 4.

Association between falls in Alzheimer disease and scores on the Balance Evaluation Systems Test (BESTest) and MiniBESTest

Tueth LE, Earhart GM, Rawson KS.

Somatosens Mot Res. 2021 Sep;38(3):248-252. doi: 10.1080/08990220.2021.1959309. Epub 2021 Aug 5.

Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease

Ji W, Gong B, Jin H, Chen X, Li P, Cheng W, Zhao Y, He B, Zhuang J, Gao J, Yin Y.

Mini Rev Med Chem. 2021;21(19):3062-3072. doi: 10.2174/1389557521666210805110920.

Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S.

Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6.

Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions

Nascimento-Dos-Santos G, de-Souza-Ferreira E, Linden R, Galina A, Petrs-Silva H.

Cells. 2021 Jul 20;10(7):1827. doi: 10.3390/cells10071827.

Comparative Efficacy of Active Group Music Intervention versus Group Music Listening in Alzheimer's Disease

Gómez-Gallego M, Gómez-Gallego JC, Gallego-Mellado M, García-García J.

Int J Environ Res Public Health. 2021 Jul 30;18(15):8067. doi: 10.3390/ijerph18158067.

Dysregulation of Astrocyte-Neuronal Communication in Alzheimer's Disease

Nanclares C, Baraibar AM, Araque A, Kofuji P.

Int J Mol Sci. 2021 Jul 23;22(15):7887. doi: 10.3390/ijms22157887.

Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review

Yu TW, Lane HY, Lin CH.

Int J Mol Sci. 2021 Jul 30;22(15):8208. doi: 10.3390/ijms22158208.

The Ultrastructure of Tissue Damage by Amyloid Fibrils

Koike H, Katsuno M.

Molecules. 2021 Jul 29;26(15):4611. doi: 10.3390/molecules26154611.

Cellular senescence at the crossroads of inflammation and Alzheimer's disease

Guerrero A, De Strooper B, Arancibia-Cárcamo IL.

Trends Neurosci. 2021 Sep;44(9):714-727. doi: 10.1016/j.tins.2021.06.007. Epub 2021 Aug 5.

NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease

Van Zeller M, Dias D, Sebastião AM, Valente CA.

J Alzheimers Dis. 2021;83(3):939-961. doi: 10.3233/JAD-210268.

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease

Mukhopadhyay S, Banerjee D.

J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias